Pivikto 200mg Tablet
Marketer
Novartis India Ltd
Salt Composition
Alpelisib (200mg)
Overview Pivikto 200mg Tablet
Alpelisib 200mg tablets are indicated for treating specific advanced breast cancers. These include hormone receptor-positive, HER2-negative, PIK3CA-mutated breast cancers that have metastasized. This medication is always administered concurrently with hormonal anti-cancer therapies. For optimal absorption, consume Alpelisib 200mg tablets with food, consistently at the same time daily. Dosage and frequency are determined individually by your physician, varying based on your condition and potentially adjusted over time. Strict adherence to your doctor's prescribed regimen is crucial; improper use or overdose can lead to serious adverse events. Therapeutic benefits may not be immediately apparent, often taking weeks or months; discontinue use only under your doctor's instruction. Frequently reported side effects include tiredness, reduced appetite, skin rashes, nausea, and diarrhea. A decrease in blood cell counts (both red and white) may heighten infection risk. Report any infection symptoms (fever, chills, weakness, unusual bleeding or bruising, nosebleeds) to your physician. Dizziness is another potential side effect; avoid driving or activities requiring alertness if affected. Prior to commencing treatment, disclose any pre-existing heart, liver, or kidney conditions, and all medications, including those for infections, to your doctor. Alpelisib may interact with other drugs; ensure complete disclosure of all medications to your healthcare provider. This medication is contraindicated during pregnancy and breastfeeding. Reliable contraception is essential for both partners throughout the treatment period. A patient support program, administered by Tata 1mg, is available in India. Consult your physician for further information or call 1800-102-1618.
Uses of Pivikto 200mg Tablet
Managing Breast Cancer
Major Benefits of Pivikto 200mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Pivikto 200mg Tablet whole; do not break, crush, or chew it. Administer this medication with a meal.
Common Side effects of Pivikto 200mg Tablet:
- Diarrhea
- Rash
- Increased glucose level in blood
- Nausea
- Vomiting
- Fatigue
- Increased creatinine level in blood
- Lymphocytopenia
- Increased gamma-glutamyltransferase
- Increased alanine aminotransferase
- Decreased hemoglobin
- Increased lipase in the blood
- Decreased appetite
- Stomatitis (Inflammation of the mouth)
- Weight loss
- Hypoglycemia (low blood glucose level)
- Decreased calcium level in blood
- Prolonged activated partial thromboplastin time (aPTT)
- Hair loss
How to use Pivikto 200mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the 200mg Pivikto Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
How Pivikto 200mg Tablet works:
Pivikto 200mg tablets combat cancer by inhibiting the signals that stimulate cancerous cell proliferation, thus hindering tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of combining Pivikto 200mg Tablet with alcohol is undetermined. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
Use of Pivikto 200mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against possible risks prior to prescription. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Lactation and the use of Pivikto 200mg tablets are likely incompatible. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
Pivikto 200mg Tablet's impact on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data regarding Pivikto 200mg Tablet use in patients exhibiting renal impairment is scarce. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The 200mg Pivikto tablet may be administered safely to individuals with hepatic impairment. No alteration of the Pivikto 200mg tablet dosage is necessary.
What if you forget to take Pivikto 200mg Tablet :
NA
Facts to Know About Pivikto 200mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Proline-based compounds |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
3,018 People bought this recently
